NPORT-EX 2 JPMLCV.htm EDGAR HTML
JPMorgan Large Cap Value Fund
Schedule of Portfolio Investments as of March 31, 2025
(Unaudited)
THE “UNAUDITED MUTUAL FUNDS HOLDINGS” LIST (“the
List”) IS TO BE USED FOR REPORTING PURPOSES ONLY. IT IS
NOT TO BE REPRODUCED FOR USE AS ADVERTISING OR
SALES LITERATURE WITH THE GENERAL PUBLIC. The list is
submitted for the general information of the shareholders of the Fund.
It is not authorized for distribution to prospective investors in the Fund
unless preceded or accompanied by a prospectus. The list has been
created from the books and records of the Fund. Holdings are
available 60 days after the fund’s fiscal quarter, using a trade date
accounting convention, by contacting the appropriate service center.
The list is subject to change without notice. The list is for
informational purposes only and is not intended as an offer or
solicitation with respect to the purchase or sale of any security.
JPMorgan Asset Management is the marketing name for the asset
management business of J.P. Morgan Chase & Co.
J.P. Morgan Distribution Services, Inc., member FINRA.
© J.P. Morgan Chase & Co., 2025.

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — 97.4%
Aerospace & Defense — 2.1%
RTX Corp.
558
73,943
Textron, Inc.
376
27,184
 
101,127
Automobile Components — 0.6%
Gentex Corp.
1,345
31,336
Banks — 11.4%
Bank of America Corp.
3,929
163,943
Comerica, Inc.
394
23,236
Fifth Third Bancorp
1,515
59,404
First Citizens BancShares, Inc., Class A
46
85,514
First Horizon Corp.
1,369
26,593
Truist Financial Corp.
909
37,413
Wells Fargo & Co.
2,154
154,615
 
550,718
Beverages — 1.8%
Constellation Brands, Inc., Class A
82
14,970
PepsiCo, Inc.
485
72,731
 
87,701
Biotechnology — 4.8%
AbbVie, Inc.
550
115,269
BioMarin Pharmaceutical, Inc.*
334
23,601
Neurocrine Biosciences, Inc.*
125
13,847
Regeneron Pharmaceuticals, Inc.
126
79,532
 
232,249
Broadline Retail — 0.2%
Amazon.com, Inc.*
50
9,561
Building Products — 1.3%
Carrier Global Corp.
1,016
64,391
Capital Markets — 1.4%
Ameriprise Financial, Inc.
57
27,747
CME Group, Inc.
92
24,247
Jefferies Financial Group, Inc.
298
15,957
 
67,951
Chemicals — 2.3%
Axalta Coating Systems Ltd.*
1,002
33,253
Chemours Co. (The)
2,818
38,129
FMC Corp.
488
20,579
Linde plc
43
20,063
 
112,024
Consumer Finance — 0.8%
Discover Financial Services
214
36,522
Consumer Staples Distribution & Retail — 3.7%
BJ's Wholesale Club Holdings, Inc.*
375
42,763

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Consumer Staples Distribution & Retail — continued
Performance Food Group Co.*
1,145
90,076
Walmart, Inc.
518
45,485
 
178,324
Containers & Packaging — 2.0%
Ball Corp.
1,203
62,644
Silgan Holdings, Inc.
687
35,112
 
97,756
Diversified Telecommunication Services — 3.1%
AT&T, Inc.
1,692
47,852
Verizon Communications, Inc.
2,236
101,435
 
149,287
Electric Utilities — 2.3%
Edison International
767
45,187
Southern Co. (The)
281
25,853
Xcel Energy, Inc.
546
38,621
 
109,661
Electrical Equipment — 3.7%
Eaton Corp. plc
167
45,338
Emerson Electric Co.
490
53,770
nVent Electric plc
674
35,305
Regal Rexnord Corp.
398
45,367
 
179,780
Electronic Equipment, Instruments & Components — 0.6%
TD SYNNEX Corp.
284
29,510
Entertainment — 0.6%
Walt Disney Co. (The)
293
28,894
Financial Services — 5.3%
Berkshire Hathaway, Inc., Class B*
184
97,724
Block, Inc.*
109
5,907
Corpay, Inc.*
279
97,345
Fidelity National Information Services, Inc.
324
24,216
Fiserv, Inc.*
114
25,201
MGIC Investment Corp.
244
6,047
 
256,440
Food Products — 1.1%
Lamb Weston Holdings, Inc.
350
18,665
Mondelez International, Inc., Class A
533
36,163
 
54,828
Health Care Equipment & Supplies — 1.9%
Medtronic plc
507
45,537
Zimmer Biomet Holdings, Inc.
425
48,140
 
93,677

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Health Care Providers & Services — 9.4%
Cardinal Health, Inc.
558
76,821
Cigna Group (The)
317
104,404
CVS Health Corp.
221
14,986
Elevance Health, Inc.
109
47,512
Humana, Inc.
298
78,769
Labcorp Holdings, Inc.
135
31,332
UnitedHealth Group, Inc.
192
100,815
 
454,639
Health Care REITs — 0.6%
Alexandria Real Estate Equities, Inc.
335
30,996
Hotels, Restaurants & Leisure — 0.5%
Carnival Corp.*
783
15,298
DraftKings, Inc., Class A*
318
10,538
 
25,836
Household Durables — 1.9%
DR Horton, Inc.
183
23,213
Mohawk Industries, Inc.*
506
57,828
Toll Brothers, Inc.
89
9,379
 
90,420
Industrial Conglomerates — 0.5%
3M Co.
167
24,489
Industrial REITs — 1.1%
Americold Realty Trust, Inc.
1,846
39,618
Lineage, Inc.(a)
225
13,167
 
52,785
Insurance — 4.5%
Arch Capital Group Ltd.
463
44,505
Arthur J Gallagher & Co.
161
55,557
Chubb Ltd.
164
49,580
Oscar Health, Inc., Class A*
2,901
38,027
Travelers Cos., Inc. (The)
107
28,370
 
216,039
Life Sciences Tools & Services — 0.5%
Bruker Corp.
574
23,967
Machinery — 1.4%
AGCO Corp.
231
21,414
Gates Industrial Corp. plc*
2,482
45,692
 
67,106
Media — 1.6%
Comcast Corp., Class A
2,104
77,625

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Metals & Mining — 1.2%
Alcoa Corp.
913
27,856
Steel Dynamics, Inc.
231
28,917
 
56,773
Multi-Utilities — 0.6%
Dominion Energy, Inc.
540
30,278
Oil, Gas & Consumable Fuels — 2.8%
ConocoPhillips
291
30,545
Exxon Mobil Corp.
645
76,696
Hess Corp.
183
29,299
 
136,540
Passenger Airlines — 1.5%
Copa Holdings SA, Class A (Panama)
104
9,587
Southwest Airlines Co.
1,852
62,204
 
71,791
Pharmaceuticals — 1.9%
Bristol-Myers Squibb Co.
1,549
94,450
Professional Services — 0.8%
Genpact Ltd.
626
31,547
TransUnion
115
9,542
 
41,089
Real Estate Management & Development — 0.4%
Zillow Group, Inc., Class C*
265
18,200
Residential REITs — 1.9%
American Homes 4 Rent, Class A
1,219
46,116
Equity LifeStyle Properties, Inc.
673
44,875
 
90,991
Specialized REITs — 4.6%
American Tower Corp.
367
79,819
Digital Realty Trust, Inc.
474
67,903
SBA Communications Corp.
343
75,507
 
223,229
Specialty Retail — 1.3%
Best Buy Co., Inc.
238
17,535
Murphy USA, Inc.
99
46,228
 
63,763
Technology Hardware, Storage & Peripherals — 2.1%
Seagate Technology Holdings plc
425
36,124
Western Digital Corp.*
1,632
65,987
 
102,111
Textiles, Apparel & Luxury Goods — 0.4%
Kontoor Brands, Inc.
284
18,248

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
INVESTMENTS
SHARES
(000)
VALUE
($000)
Common Stocks — continued
Tobacco — 3.1%
Philip Morris International, Inc.
940
149,172
Trading Companies & Distributors — 1.8%
AerCap Holdings NV (Ireland)
694
70,921
WESCO International, Inc.
91
14,054
 
84,975
Total Common Stocks
(Cost $4,363,397)
4,717,249
Short-Term Investments — 1.8%
Investment Companies — 1.8%
JPMorgan Prime Money Market Fund Class IM Shares, 4.43%(b) (c)
(Cost $87,606)
87,581
87,607
Investment of Cash Collateral from Securities Loaned — 0.0% ^
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 4.38%(b) (c)
(Cost $278)
278
278
Total Short-Term Investments
(Cost $87,884)
87,885
Total Investments — 99.2%
(Cost $4,451,281)
4,805,134
Other Assets in Excess of Liabilities — 0.8%
40,371
NET ASSETS — 100.0%
4,845,505

Percentages indicated are based on net assets.
Abbreviations
 
REIT
Real Estate Investment Trust
^
Amount rounds to less than 0.1% of net assets.
*
Non-income producing security.
 
(a)
The security or a portion of this security is on loan at March 31, 2025. The total value of securities on loan at March 31, 2025 is $268.
 
(b)
Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan
Investment Management Inc.
 
(c)
The rate shown is the current yield as of March 31, 2025.
 

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
(Dollar values in thousands)
A. Valuation of Investments Investments are valued in accordance with U.S. generally accepted accounting principles (“GAAP”) and the Fund's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the “Board”), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the Investment Company Act of 1940, the Board is required to determine fair value for securities that do not have readily available market quotations. Under Securities and Exchange Commission Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Fund on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of investments held in the Fund. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values (“NAV”) of the Fund are calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Fund's investments are summarized into the three broad levels listed below.
Level 1 Unadjusted inputs using quoted prices in active markets for identical investments.
Level 2 Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
Level 3 Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Fund's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments (“SOI”):
 
 
 
 
 
 
Level 1
Quoted prices
Level 2
Other significant
observable inputs
Level 3
Significant
unobservable inputs
Total
Total Investments in Securities(a)
$4,805,134
$
$
$4,805,134

 
(a)
Please refer to the SOI for specifics of portfolio holdings.
B. Investment Transactions with Affiliates The Fund invested in Underlying Funds advised by the Adviser. An issuer which is under common control with the Fund may be considered an affiliate. The Fund assumes the issuers listed in the table below to be affiliated issuers.

JPMorgan Large Cap Value Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2025 (Unaudited) (continued)
(Dollar values in thousands)
The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
 
For the period ended March 31, 2025
Security Description
Value at
June 30,
2024
Purchases at
Cost
Proceeds from
Sales
Net Realized
Gain (Loss)
Change in
Unrealized
Appreciation/
(Depreciation)
Value at
March 31,
2025
Shares at
March 31,
2025
Dividend
Income
Capital Gain
Distributions
JPMorgan Prime Money Market Fund Class IM
Shares, 4.43% (a) (b)
$127,054
$2,344,269
$2,383,734
$17
$1
$87,607
87,581
$3,508
$
JPMorgan Securities Lending Money Market Fund
Agency SL Class Shares, 4.38% (a) (b)
2,000
106,281
108,004
1
278
278
208
JPMorgan U.S. Government Money Market Fund
Class IM Shares, 4.31% (a) (b)
1,210
14,734
15,944
16
Total
$130,264
$2,465,284
$2,507,682
$18
$1
$87,885
$3,732
$

 
(a)
Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan
Investment Management Inc.
(b)
The rate shown is the current yield as of March 31, 2025.